Earnings › Eli Lilly · Eli Lilly company page · insider trades
Eli Lilly earnings
Eli Lilly (LLY) quarterly revenue, net income and diluted EPS from its SEC filings, the upcoming report date, and links to each earnings release. Last update 2026-11-11.
Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio(Eli Lilly press release headline)
Press release (Ex. 99.1) ↗ · 8-K filing on SEC EDGAR ↗
Subscribe to Eli Lilly earnings dates in your calendar app (updates automatically)
Also reporting around the same time
- Verizon · Oct 26, 2026
- American Tower · Oct 27, 2026
- Boeing · Oct 27, 2026
- Centene Corporation · Oct 27, 2026
- UPS · Oct 27, 2026
- Alphabet (Google) · Oct 28, 2026
- GE Vernova · Oct 28, 2026
- Meta · Oct 28, 2026 (not yet confirmed)
Quarterly results
| Quarter | Revenue | YoY | Net income | YoY | Diluted EPS |
|---|---|---|---|---|---|
| Q3 2026 ended Sep 30, 2026 | $24.40B | +39% | $6.45B | +16% | $7.22 |
| Q2 2026 ended Jun 30, 2026 | $22.97B | +48% | $7.09B | +25% | $7.94 |
| Q1 2026 ended Mar 31, 2026 | $19.80B | +56% | $7.40B | +168% | $8.26 |
| Q4 2025 ended Dec 31, 2025 · from annual report | $19.29B | +43% | $6.64B | +51% | — |
| Q3 2025 ended Sep 30, 2025 | $17.60B | — | $5.58B | — | $6.21 |
| Q2 2025 ended Jun 30, 2025 | $15.56B | — | $5.66B | — | $6.29 |
| Q1 2025 ended Mar 31, 2025 | $12.73B | — | $2.76B | — | $3.06 |
| Q4 2024 ended Dec 31, 2024 · from annual report | $13.53B | — | $4.41B | — | — |
Earnings releases (Form 8-K, Item 2.02)
- Oct 29, 2026: 8-K filing and press release ↗ ·
Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio
- Aug 5, 2026: 8-K filing and press release ↗
- Apr 30, 2026: 8-K filing and press release ↗
- Feb 4, 2026: 8-K filing and press release ↗
- Oct 30, 2025: 8-K filing and press release ↗
- Aug 7, 2025: 8-K filing and press release ↗
- May 1, 2025: 8-K filing and press release ↗
- Feb 6, 2025: 8-K filing and press release ↗
Source: SEC EDGAR XBRL company facts (10-Q and 10-K) and 8-K filings. Quarters marked "from annual report" are the annual total minus the three reported quarters, because Eli Lilly reports its fourth quarter only inside the annual report; EPS is not derived for those quarters. Figures are as reported under US GAAP. Not investment advice.
FAQ
Q When did Eli Lilly report Q3 2026 results?
A Eli Lilly released Q3 2026 results on Thursday, Oct 29, 2026, in a press release filed with the SEC on Form 8-K.
Q What were Eli Lilly's latest quarterly results?
A For Q3 2026 (ended Sep 30, 2026), Eli Lilly reported revenue of $24.40B and net income of $6.45B, or $7.22 per diluted share, according to its 10-Q filed Oct 29, 2026.